Carl Magnus Högerkorp
Directeur Général chez CYXONE AB
Postes actifs de Carl Magnus Högerkorp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CYXONE AB | Directeur/Membre du Conseil | 01/01/2023 | - |
| Directeur Général | 20/06/2022 | - | |
| Investor Relations Contact | - | - | |
| Directeur des opérations | 20/05/2021 | 13/12/2022 |
Historique de carrière de Carl Magnus Högerkorp
Anciens postes connus de Carl Magnus Högerkorp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Directeur Général | 01/01/2019 | 01/04/2021 |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Directeur Général | 01/05/2017 | 01/10/2018 |
| XINTELA AB | Directeur Technique/Scientifique/R&D | 01/01/2016 | 01/04/2017 |
| Immodulate Pharma AB | Directeur Général | 01/01/2021 | - |
| Fondateur | 01/01/2021 | - |
Formation de Carl Magnus Högerkorp
| University of Lund | Doctorate Degree |
| Lund University School of Economics & Management | Masters Business Admin |
Statistiques
Internationale
| Suède | 8 |
Opérationnelle
| Chief Executive Officer | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| XINTELA AB | Health Technology |
| CYXONE AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Edvince AB
Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
| Immodulate Pharma AB |
- Bourse
- Insiders
- Carl Magnus Högerkorp
- Expérience